Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood

References

• Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 1999; 96: 9118–23
   PubMed Web of Science ®Google Scholar
• Hess DA, Meyerrose TE, Wirthlin L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004; 104: 1648–55
   PubMed Web of Science ®Google Scholar
• Storms RW, Green PD, Safford KM, et al. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 2005; 106: 95–102
   PubMed Web of Science ®Google Scholar
• Hess DA, Wirthlin L, Craft TP, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162–9
   PubMed Web of Science ®Google Scholar
• Fallon P, Gentry T, Balber AE, et al. Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol 2003; 122: 99–108
   PubMed Web of Science ®Google Scholar
• Lioznov MV, Freiberger P, Kroger N, et al. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 35: 909–14
   PubMed Web of Science ®Google Scholar
• Gentry T, Foster SJ, Winstead L, et al. Simultaneous isolation of human bone marrow hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy 2007; 9: 259–74
   Web of Science ®Google Scholar
• Staba SL, Escolar ML, Poe M, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960–9
   PubMed Web of Science ®Google Scholar
• Martin PL, Carter SL, Kernan NA, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006; 12: 184–94
   PubMed Web of Science ®Google Scholar
• Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord Cord Blood Transplant Group. Blood 1999; 93: 3662–71
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–66
   PubMed Web of Science ®Google Scholar
• Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–75
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Wagner JE. Umbilical cord blood transplantation and banking. Annu Rev Med 2006; 57: 403–17
   PubMed Web of Science ®Google Scholar
• Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12: 34–41
   PubMedGoogle Scholar
• Jones RJ, Zuehlsdorf M, Rowley SD, et al. Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation. Blood 1987; 70: 1490–4
   PubMed Web of Science ®Google Scholar
• Kastan MB, Schlaffer E, Russo JE, et al. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990; 75: 1947–50
   PubMed Web of Science ®Google Scholar
• Gordon MY, Goldman JM, Gordon-Smith EC. 4-Hydroperoxycyclophosphamide inhibits proliferation by human granulocyte–macrophage colony-forming cells (GM-CFC) but spares more primitive progenitor cells. Leuk Res 1985; 9: 1017–21
   PubMed Web of Science ®Google Scholar
• Kohn FR, Landkamer GJ, Manthey CL, et al. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res 1987; 47: 3180–5
   PubMed Web of Science ®Google Scholar
• Rowley SD, Colvin OM, Stuart RK. Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol 1985; 13: 295–8
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Ratajczak J, Kuczynski W, et al. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Exp Hematol 1993; 21: 1663–7
   Google Scholar